Salivary biomarkers indicate obstructive sleep apnea patients with cardiovascular diseases

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Zheng, Hui ^a   Li, Ruoxuan ^b   Zhang, Jieni ^a   Zhou, Shaonan ^a   Ma, Qingwei ^c   Zhou, Yanheng ^a   Chen, Feng ^a   Lin, Jiuxiang ^a  

^a PEKING UNIVERSITY SCHOOL AND HOSPITAL OF STOMATOLOGY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c Technology   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ADULT; AGED; CARDIOVASCULAR DISEASES; CHEMISTRY; COMPLICATION; FEMALE; HUMAN; MALE; MASS SPECTROMETRY; METABOLISM; MIDDLE AGED; PROGNOSIS; REPRODUCIBILITY; RISK FACTOR; SALIVA; SENSITIVITY AND SPECIFICITY; SLEEP APNEA, OBSTRUCTIVE;

ADULT; AGED; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RISK FACTORS; SALIVA; SENSITIVITY AND SPECIFICITY; SLEEP APNEA, OBSTRUCTIVE; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84923277937     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep07046     Document Type: Article

References (24)

1. Wei, X. et al. Characteristics of high risk people with cardiovascular disease in chinese rural areas: clinical indictors, disease patterns and drug treatment. PLoS One 8, e54169 (2013).
2. Hu, S. S. et al. Outline of the report on cardiovascular disease in China, 2010. Biomedical and environmental sciences: BES 25, 251-256 (2012).
3. Ursavas, A. & Ege, E. [Obstructive sleep apnea and cardiovascular diseases]. Anadolu Kardiyol Derg 3, 150-155 (2003).
4. Marin, J. M. et al. Association between treated and untreated obstructive sleep apnea and risk of hypertension. JAMA 307, 2169-2176 (2012).
5. Das, A. M. & Khan, M. Obstructive sleep apnea and stroke. Expert Rev Cardiovasc Ther 10, 525-535 (2012).
6. Sunderram, J. & Androulakis, I. P. Molecular mechanisms of chronic intermittent hypoxia and hypertension. Crit Rev Biomed Eng 40, 265-278 (2012).
7. Peker, Y., Hedner, J., Kraiczi, H. & Loth, S. Respiratory disturbance index: an independent predictor of mortality in coronary artery disease. Am J Respir Crit Care Med 162, 81-86 (2000).
8. Caples, S. M., Gami, A. S. & Somers, V. K. Obstructive sleep apnea. Ann Intern Med 142, 187-197 (2005).
9. Tamas, J., Mak, M., Klebovich, I., Vereczkey, L. & Toth, E. Mass spectrometric characterization of some human metabolites of flumecinol. Biomed Environ Mass Spectrom 15, 229-232 (1988).
10. Chiappin, S., Antonelli, G., Gatti, R. & De Palo, E. F. Saliva specimen: a new laboratory tool for diagnostic and basic investigation. Clin Chim Acta 383, 30-40 (2007).
11. Aurer, A., Jorgic-Srdjak, K., Plancak, D., Stavljenic-Rukavina, A. & Aurer-Kozelj, J. Proinflammatory factors in saliva as possible markers for periodontal disease. Coll Antropol 29, 435-439 (2005).
12. Giusti, L. et al. Proteome analysis of whole saliva: a new tool for rheumatic diseases - the example of Sjogren's syndrome. Proteomics 7, 1634-1643 (2007).
13. Tanaka, K., Waki, H. & Ido, Y. Protein and polymer analyses up to m/z 100 000 by laser ionization time-of-flight mass spectrometry. Rapid Commun.Mass Spectrom 2, 151-C153 (1988).
14. Zhang, J. et al. Magnetic bead-based salivary peptidome profiling analysis during orthodontic treatment durations. Biochem Biophys Res Commun 421, 844-849 (2012).
15. Davis, N. E. Atherosclerosis - an inflammatory process. J Insur Med 37, 72-75 (2005).
16. Tracy, R. P. Epidemiological evidence for inflammation in cardiovascular disease. Thromb Haemost 82, 826-831 (1999).
17. Levy, P. et al. Sleep deprivation, sleep apnea and cardiovascular diseases. Front Biosci (Elite Ed) 4, 2007-2021 (2012).
18. Jarai, T. et al. Mass spectrometry-based salivary proteomics for the discovery of head and neck squamous cell carcinoma. Pathol Oncol Res 18, 623-628 (2012).
19. Barcelo, A. et al. Reduced plasma fetuin-A levels in patients with obstructive sleep apnoea. The European respiratory journal 40, 1046-1048, doi:10.1183/ 09031936.00011912 (2012).
20. Harris, V. K. et al. Cerebrospinal fluid fetuin-A is a biomarker of active multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England), doi:10.1177/ 1352458513477923 (2013).
21. Zhou, H. et al. Exosomal Fetuin-A identified by proteomics: a novel urinary biomarker for detecting acute kidney injury. Kidney international 70, 1847-1857, doi:10.1038/sj.ki.5001874 (2006).
22. Yasuda, T. et al. Alpha-2-HS-glycoprotein (AHSG) polymorphism in semen and saliva. Electrophoresis 17, 793-796, doi:10.1002/elps.1150170429 (1996).
23. Mori, K., Emoto, M. & Inaba, M. Fetuin-A and the cardiovascular system. Advances in clinical chemistry 56, 175-195 (2012).
24. Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society. Series B (Methodological), 289-300 (1995).